Standardize for the Population, Personalize for the Person

My father was 50 years old when I was born, and decades later I learned a lot while tending to him as he was battling Alzheimer's. That experience is why I reject a debate that health system leaders keep having.

They often talk about population health and personalized medicine as if they sit at opposite ends of a spectrum. One is about communities, averages and scale. The other is about genomes, wearables and the individual.

I don't see a trade-off. We can standardize for the population while also personalizing for the individual. With chronic disease rising and cost pressure relentless, the systems that thrive will be the ones that learn to do both at once.

Why This Is Personal for Me

I'm of Hispanic descent. My parents fled Cuba after Castro's revolution.

What I learned caring for my father is that care doesn't end at the clinic door. It continues at the kitchen table, in the car on the way to appointments and in the late-night decisions families make on their own. In many families, including mine, caregiving is simply what you do. Those families become an extension of the care team, whether the health system recognizes them or not.

That reality is enormous. AARP and the National Alliance for Caregiving's Caregiving in the US 2025 report found that 63 million Americans are now family caregivers. Any population health strategy that ignores them is incomplete, and any personalized care plan that doesn't account for them is fragile.

Innovation Won't Save Us Without Trust

We can't help people live healthy lives if we don't have their trust. Many communities carry a long history of feeling unseen by healthcare, and that history shapes whether they seek care early, follow a plan or participate in clinical research.

In my conversations with health system leaders, the ones earning trust share a mindset: they strive to be of the community, not just in it. That shows up in practical ways. A clinic staffed by clinicians who speak the language of the neighborhood it serves. Partnerships with community leaders on prevention and early detection. A recognition that what works for one community often benefits everyone.

The Cancer Resides in the Person

Clinical practice is where these ideas are tested. Healthcare, like any industry, faces the quandary of needing both standardization and personalization. Standards of care protect safety and efficiency. Precision medicine lets us tailor treatment to biology.

Leading oncologists have put it well: the disease resides in the patient, and the individual features of the patient matter as much as the biology of the disease. Their stress, their environment, their resources and their resilience all shape outcomes. Research on why people age at different rates points in the same direction.

But clinical capability is not the same as organizational readiness. If I track my own metrics and get my DNA sequenced, but end up with a health plan and provider network that aren't set up to take advantage of it, I am still missing out on the personalization I expect. The system has to be designed for it.

That design work belongs to leaders, not only to clinicians. It means connecting genomic and clinical insight to benefits, networks, scheduling and follow-up, so the promise made in the exam room is kept everywhere else the patient goes.

What Personalization Looks Like at the Bedside

Some of the most powerful practices I've seen are simple. Hospitals that let patient and family advisory councils shape how care is delivered. Nurses who capture a patient's life story and keep it visible in the room, so every caregiver sees the person before the diagnosis. Dedicated minutes at the bedside to talk about something other than the illness.

These are not expensive technologies. They are signals that the organization knows who it is caring for, and they are what patients will remember long after the discharge papers.

Be Of the Community, Not Just In It

• Do we have processes to get to know patients as individuals, and to share that knowledge across the continuum of care?
• Do we see family caregivers as part of the care team, and do we equip them?
• Where are we in the community, and where are we of it?
• Are the people we serve represented in the research and insights that shape our care?
• Once a patient is discharged, who makes sure the plan still fits their life?

The Risk We Can't Afford

Everything comes back to getting to know people as individuals, and structuring organizations to welcome every individual at every level. That's the same conviction that drove the conversations at the Healthcare in the Age of Personalization summit I hosted.

As medical innovation advances beyond what we once imagined, if we're not getting those advancements to the people who need them, we risk becoming the most medically innovative yet unhealthy nation in history. Healthcare can no longer be led like a cottage industry. It has to be led for the person, at the scale of the population.

Want to explore these ideas further? Learn more about my work on leadership, identity and conviction at www.theglennllopis.com.